The general stigma and bias circulating obesity hinders the ability to improve the patient’s health, explained Ted Kyle, RPh, MBA, principal at ConscienHealth. With number of individuals with obesity, patients, physicians, and payers can’t afford to think of obesity as a purely cosmetic condition.
The general stigma and bias circulating obesity hinders the ability to improve the patient’s health, explained Ted Kyle, RPh, MBA, principal at ConscienHealth. With number of individuals with obesity, patients, physicians, and payers can’t afford to think of obesity as a purely cosmetic condition.
Transcript (slightly modified)
How has bias and stigma among the general public affected the treatment of obesity?
People generally assume that obesity is strictly a matter of personal choices, the product of bad choices about physical activity and diet and that gets in the way of actually dealing with obesity as a health condition. And when you get right down to it, obesity is a very complicated factor. About 50 to 70% of one’s risk of obesity is genetically determined. You can make choices that make it better or worse but that’s just like any other chronic disease. And, when that blame and shame that is so common gets in the way, it makes it hard to actually improve the health of people living with obesity.
How has the misconception that obesity is a visually apparent disease hindered treatment?
Well what happens is that a lot of health plans have had broad, blanket exclusions for obesity, thinking that it is a cosmetic condition. But, the rise in the prevalence of obesity that’s happened over the last 3 decades has made it clear that it’s creating a burden of chronic disease ranging from cardiovascular disease to diabetes to many cancers, and really diseases, chronic diseases of virtually every organ system in the body so you can’t really afford to think of it as a cosmetic condition. Although, people get fixated on that.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Infant Mortality Increases Across US Following Dobbs Decision
October 25th 2024The Dobbs decision was associated with a 7% absolute increase in overall infant mortality—equivalent to 247 excess deaths—and a 10% increase among infants with congenital anomalies, corresponding to 204 additional deaths.
Read More